PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Kabbani, N.* ; Blüher, M. ; Stepan, H.* ; Stumvoll, M.* ; Ebert, T.* ; Tönjes, A.* ; Schrey-Petersen, S.*

Adipokines in pregnancy: A systematic review of clinical data.

Biomedicines 11:25 (2023)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Adipokines are signaling proteins involved in metabolic, endocrinological, vascular and immunogenic processes. Associations of various adipokines with not only insulin resistance but also with increased insulin sensitivity, increased systolic blood pressure, and atherosclerosis highlight the significance of adipokines in several components of metabolic syndrome and metabolic diseases in general. As pregnancy presents a unique metabolic state, the role of adipokines in pregnancy, and even in various pregnancy complications, appears to be key to elucidating these metabolic processes. Many studies in recent years have attempted to clarify the role of adipokines in pregnancy and gestational pathologies. In this review, we aim to investigate the changes in maternal adipokine levels in physiological gestation, as well as the association of adipokines with pregnancy pathologies, such as gestational diabetes mellitus (GDM) and preeclampsia (PE). Furthermore, we will analyze the association of adipokines in both maternal serum and cord blood with parameters of intrauterine growth and various pregnancy outcomes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.700
0.000
4
2
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Review
Keywords Adipokines ; Gestational Diabetes ; Intrauterine Growth ; Preeclampsia ; Pregnancy; Gestational Diabetes-mellitus; Retinol-binding-protein; Maternal Serum Resistin; Adipose-tissue; 1st Trimester; Chemerin Level; Birth-weight; Visfatin Concentrations; Insulin-resistance; Omentin-1 Levels
Language english
Publication Year 2023
HGF-reported in Year 2023
ISSN (print) / ISBN 2227-9059
e-ISSN 2227-9059
Journal Biomedicines
Quellenangaben Volume: 11, Issue: 5, Pages: , Article Number: 25 Supplement: ,
Publisher MDPI
Publishing Place Basel, Switzerland
Reviewing status Peer reviewed
Institute(s) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-506501-001
Grants EFSD Mentorship Programme - AstraZeneca
Swedish Kidney Foundation (Njurfonden)
Deutsche Diabetes Gesellschaft (DDG)
Stiftelsen Stig och Gunborg Westman
Karolinska Institutet Research Foundation
Karolinska Institutet, Stockholm, Sweden
Novo Nordisk postdoctoral fellowship
medical faculty of the University of Leipzig
German Diabetes Association (DDG)
Deutsches Zentrum fur Diabetesforschung (DZD)
Deutsche Forschungsgemeinschaft (DFG, German Research foundation)
DOI 10.3390/biomedicines11051419
WOS ID 001011296600001
Scopus ID 85160725598
PubMed ID 37239090
Erfassungsdatum 2023-10-06
[➜Report correction]